Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $118.2000 (1.62%) ($116.3100 - $119.5900) on Thu. Mar. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 50 | Latest Price | $118.2000(1.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.1% a day on average for past five trading days. | Weekly Trend | LGND declines -4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.79% in a week (0% probabilities). VXX(-15%) TLT(-15%) VIXM(-10%) UUP(-10%) IFRA(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | 0 () | Intraday Trend | 1.6% | | | |
|
1 - 5 Day Possible Target | $103.2(-12.69%) | 5 Day Moving Average | $112.95(4.65%) | 10 Day Moving Average | $114.58(3.16%) | 20 Day Moving Average | $117.88(0.27%) | To recent high | -17% | To recent low | 11.6% | Market Cap | $1.9b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |